PRPF3

Chr 1AD

pre-mRNA processing factor 3

Also known as: HPRP3, HPRP3P, PRP3, Prp3p, RP18, SNRNP90

The removal of introns from nuclear pre-mRNAs occurs on complexes called spliceosomes, which are made up of 4 small nuclear ribonucleoprotein (snRNP) particles and an undefined number of transiently associated splicing factors. This gene product is one of several proteins that associate with U4 and U6 snRNPs. Mutations in this gene are associated with retinitis pigmentosa-18. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.071 OMIM phenotype
Clinical SummaryPRPF3
🧬
Gene-Disease Validity (ClinGen)
retinitis pigmentosa 18 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
12 unique Pathogenic / Likely Pathogenic· 192 VUS of 447 total submissions
📖
GeneReview available — PRPF3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.07LOEUF
pLI 1.000
Z-score 6.12
OE 0.00 (0.000.07)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
3.85Z-score
OE missense 0.44 (0.380.50)
160 obs / 367.6 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.00 (0.000.07)
00.351.4
Missense OE?0.44 (0.380.50)
00.61.4
Synonymous OE?0.94
01.21.6
LoF obs/exp: 0 / 43.6Missense obs/exp: 160 / 367.6Syn Z: 0.57
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePRPF3-related retinitis pigmentosaOTHERAD

This gene — mechanism propensity

DN
0.4190th %ile
GOF
0.2795th %ile
LOF
0.75top 10%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 33% of P/LP variants are LoF · LOEUF 0.07
DN1 literature citation
GOF1 literature citation

Literature Evidence

DNWe delineate the correlation between specific PRPF31 genotype and RP phenotype, suggesting that, except in cases of complete gene deletion or large-scale deletions, dominant negative effects contribute to phenotype as well as haploinsufficiency.1
GOFThese models suggest that RP18 is not a result of haploinsufficiency but instead arises from a toxic gain of function caused by missense mutations in PRPF3.2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

447 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic5
VUS192
Likely Benign167
Benign41
Conflicting13
7
Pathogenic
5
Likely Pathogenic
192
VUS
167
Likely Benign
41
Benign
13
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
5
0
0
7
Likely Pathogenic
2
3
0
0
5
VUS
5
163
18
6
192
Likely Benign
0
5
69
93
167
Benign
1
1
35
4
41
Conflicting
13
Total10177122103425

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

13 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap PRPF3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PRPF3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →